Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aflibercept (zaltrap) (1 trial)
alt-p7 (1 trial)
trastuzumab (herceptin) (1 trial)
Breast Neoplasms (Phase 1)
Macular Degeneration (Phase 1)
Wet Macular Degeneration (Phase 1)
Trials (3 total)
Trial APIs (3 total)